Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry
The main indication of covered stents (CS) is coronary artery perforation (CAP), but, they have been increasingly used in other scenarios. Data on the long-term follow-up of CS is limited, and no studies have been conducted specifically using new-generation polyurethane-covered cobalt-chromium Papyr...
Gespeichert in:
| Veröffentlicht in: | Cardiovascular revascularization medicine 2021-08, Vol.29, p.22-28 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 28 |
|---|---|
| container_issue | |
| container_start_page | 22 |
| container_title | Cardiovascular revascularization medicine |
| container_volume | 29 |
| creator | Jurado-Román, Alfonso Rodríguez, Oriol Amat, Ignacio Romani, Sebastián A. García-Touchard, Arturo Cruz-González, Ignacio Benito-González, Tomás Fernández-Cisnal, Agustín Córdoba-Soriano, Juan G. Subinas, Asier Hernández-Antolín, Rosana Bayón, Jeremías García-Tejada, Julio Salinas, Pablo Cortés, Carlos Lozano, Fernando Bastante, Teresa Núñez-Gil, Iván J. Moreno, Raúl López-Sendón, José Luis |
| description | The main indication of covered stents (CS) is coronary artery perforation (CAP), but, they have been increasingly used in other scenarios. Data on the long-term follow-up of CS is limited, and no studies have been conducted specifically using new-generation polyurethane-covered cobalt-chromium Papyrus CS. Purpose: to evaluate the clinical outcomes after hospital discharge of Papyrus CS and to compare their outcome after implantation in CAP or coronary artery aneurysms (CAA).
We evaluated the baseline clinical characteristics, lesion subsets, procedural features and the outcomes after initial discharge of Papyrus CS implanted in 17 high-PCI-volume centers.
127 Papyrus CS were implanted in 108 patients (68 ± 1 years; 82.8% male) admitted for stable coronary disease (32.3%), NSTEMI (42.4%) or STEMI (25.3%). The number of CS per patient was 1.2 ± 0.6 (diameter: 3.5 ± 1.7 mm; length: 18.5 ± 3.7 mm). Angiographic success rate was 96%. CS diameter was larger in CAA (CAP:3.04 ± 0.5 mm vs CAA:4.1 ± 2.7 mm; p = .022). Intracoronary imaging techniques were used more frequently in CAA (p |
| doi_str_mv | 10.1016/j.carrev.2020.08.017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2438675375</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1553838920304863</els_id><sourcerecordid>2438675375</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-bdf832719c9a98b306171936df22d99050768dc2c56268ac14cedcdbfab65d063</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVpINtt_0EOOvZiRx9rWe6hsJi2WVhIaJKzkKVxVottuZK8sIf892rZngsDM8PMvMz7IHRHSUkJFffH0ugQ4FQywkhJZElo_QGtqKxlQRouP-a6qnghuWxu0acYj4Twmol6hd7bwU3O6AE_Lsn4ESLe9gkC3o3zoKekk_MT9j1-8sN5CZAOeoKi9ScIYHHrOz2koj0EP7plxM8JphS_4d0U3dshRdznAU4HwE96PoclFs-zdhP-DW8upnD-jG56PUT48i-v0evPHy_tQ7F__LVrt_vCcN6korO95KymjWl0IztOBM0NF7ZnzDYNqUgtpDXMVIIJqQ3dGLDGdr3uRGWJ4Gv09ao7B_9ngZjU6KKBITsEv0TFNlyKuuI51mhzXTXBxxigV3Nwow5nRYm60FZHdaWtLrQVkSrTzmffr2eQbZwcBBWNgyn_4QKYpKx3_xf4C_APjO4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2438675375</pqid></control><display><type>article</type><title>Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry</title><source>Elsevier ScienceDirect Journals</source><creator>Jurado-Román, Alfonso ; Rodríguez, Oriol ; Amat, Ignacio ; Romani, Sebastián A. ; García-Touchard, Arturo ; Cruz-González, Ignacio ; Benito-González, Tomás ; Fernández-Cisnal, Agustín ; Córdoba-Soriano, Juan G. ; Subinas, Asier ; Hernández-Antolín, Rosana ; Bayón, Jeremías ; García-Tejada, Julio ; Salinas, Pablo ; Cortés, Carlos ; Lozano, Fernando ; Bastante, Teresa ; Núñez-Gil, Iván J. ; Moreno, Raúl ; López-Sendón, José Luis</creator><creatorcontrib>Jurado-Román, Alfonso ; Rodríguez, Oriol ; Amat, Ignacio ; Romani, Sebastián A. ; García-Touchard, Arturo ; Cruz-González, Ignacio ; Benito-González, Tomás ; Fernández-Cisnal, Agustín ; Córdoba-Soriano, Juan G. ; Subinas, Asier ; Hernández-Antolín, Rosana ; Bayón, Jeremías ; García-Tejada, Julio ; Salinas, Pablo ; Cortés, Carlos ; Lozano, Fernando ; Bastante, Teresa ; Núñez-Gil, Iván J. ; Moreno, Raúl ; López-Sendón, José Luis</creatorcontrib><description>The main indication of covered stents (CS) is coronary artery perforation (CAP), but, they have been increasingly used in other scenarios. Data on the long-term follow-up of CS is limited, and no studies have been conducted specifically using new-generation polyurethane-covered cobalt-chromium Papyrus CS. Purpose: to evaluate the clinical outcomes after hospital discharge of Papyrus CS and to compare their outcome after implantation in CAP or coronary artery aneurysms (CAA).
We evaluated the baseline clinical characteristics, lesion subsets, procedural features and the outcomes after initial discharge of Papyrus CS implanted in 17 high-PCI-volume centers.
127 Papyrus CS were implanted in 108 patients (68 ± 1 years; 82.8% male) admitted for stable coronary disease (32.3%), NSTEMI (42.4%) or STEMI (25.3%). The number of CS per patient was 1.2 ± 0.6 (diameter: 3.5 ± 1.7 mm; length: 18.5 ± 3.7 mm). Angiographic success rate was 96%. CS diameter was larger in CAA (CAP:3.04 ± 0.5 mm vs CAA:4.1 ± 2.7 mm; p = .022). Intracoronary imaging techniques were used more frequently in CAA (p < .0001). After a mean follow-up of 22 ± 16 months, the major cardiovascular adverse events (MACE) rate was 7.1% [cardiac death: 2%, Myocardial infarction: 5%, Target Lesion Revascularization: 5% and Stent Thrombosis (ST): 3%]. MACE rate was similar in CAP (7.7%) and CAA (7.1%) (p = .9). However, CAA showed a higher ST rate (CAP: 0% vs CA: 7.1%; p = .04).
After hospital discharge, clinical outcomes after Papyrus CS implantation are acceptable (considering the clinical scenario and compared with other treatment alternatives) with no significant differences in the MACE rate between those implanted in CAA or in CAP. However, CAA group showed a higher ST rate.
•Follow-up after implantation of covered stents (CS) is limited•This is the first study that specifically analyzes outcomes of new-generation CS.•After 22 ± 16 months, the rate of major cardiac adverse events is 7.1%.•MACE rate was similar between those implanted in aneurysms or perforations.•Higher stent thrombosis rate was observed in those implanted in coronary aneurysms.</description><identifier>ISSN: 1553-8389</identifier><identifier>EISSN: 1878-0938</identifier><identifier>DOI: 10.1016/j.carrev.2020.08.017</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Coronary artery aneurysms ; Coronary artery perforations ; Covered stents</subject><ispartof>Cardiovascular revascularization medicine, 2021-08, Vol.29, p.22-28</ispartof><rights>2020 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-bdf832719c9a98b306171936df22d99050768dc2c56268ac14cedcdbfab65d063</citedby><cites>FETCH-LOGICAL-c339t-bdf832719c9a98b306171936df22d99050768dc2c56268ac14cedcdbfab65d063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1553838920304863$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids></links><search><creatorcontrib>Jurado-Román, Alfonso</creatorcontrib><creatorcontrib>Rodríguez, Oriol</creatorcontrib><creatorcontrib>Amat, Ignacio</creatorcontrib><creatorcontrib>Romani, Sebastián A.</creatorcontrib><creatorcontrib>García-Touchard, Arturo</creatorcontrib><creatorcontrib>Cruz-González, Ignacio</creatorcontrib><creatorcontrib>Benito-González, Tomás</creatorcontrib><creatorcontrib>Fernández-Cisnal, Agustín</creatorcontrib><creatorcontrib>Córdoba-Soriano, Juan G.</creatorcontrib><creatorcontrib>Subinas, Asier</creatorcontrib><creatorcontrib>Hernández-Antolín, Rosana</creatorcontrib><creatorcontrib>Bayón, Jeremías</creatorcontrib><creatorcontrib>García-Tejada, Julio</creatorcontrib><creatorcontrib>Salinas, Pablo</creatorcontrib><creatorcontrib>Cortés, Carlos</creatorcontrib><creatorcontrib>Lozano, Fernando</creatorcontrib><creatorcontrib>Bastante, Teresa</creatorcontrib><creatorcontrib>Núñez-Gil, Iván J.</creatorcontrib><creatorcontrib>Moreno, Raúl</creatorcontrib><creatorcontrib>López-Sendón, José Luis</creatorcontrib><title>Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry</title><title>Cardiovascular revascularization medicine</title><description>The main indication of covered stents (CS) is coronary artery perforation (CAP), but, they have been increasingly used in other scenarios. Data on the long-term follow-up of CS is limited, and no studies have been conducted specifically using new-generation polyurethane-covered cobalt-chromium Papyrus CS. Purpose: to evaluate the clinical outcomes after hospital discharge of Papyrus CS and to compare their outcome after implantation in CAP or coronary artery aneurysms (CAA).
We evaluated the baseline clinical characteristics, lesion subsets, procedural features and the outcomes after initial discharge of Papyrus CS implanted in 17 high-PCI-volume centers.
127 Papyrus CS were implanted in 108 patients (68 ± 1 years; 82.8% male) admitted for stable coronary disease (32.3%), NSTEMI (42.4%) or STEMI (25.3%). The number of CS per patient was 1.2 ± 0.6 (diameter: 3.5 ± 1.7 mm; length: 18.5 ± 3.7 mm). Angiographic success rate was 96%. CS diameter was larger in CAA (CAP:3.04 ± 0.5 mm vs CAA:4.1 ± 2.7 mm; p = .022). Intracoronary imaging techniques were used more frequently in CAA (p < .0001). After a mean follow-up of 22 ± 16 months, the major cardiovascular adverse events (MACE) rate was 7.1% [cardiac death: 2%, Myocardial infarction: 5%, Target Lesion Revascularization: 5% and Stent Thrombosis (ST): 3%]. MACE rate was similar in CAP (7.7%) and CAA (7.1%) (p = .9). However, CAA showed a higher ST rate (CAP: 0% vs CA: 7.1%; p = .04).
After hospital discharge, clinical outcomes after Papyrus CS implantation are acceptable (considering the clinical scenario and compared with other treatment alternatives) with no significant differences in the MACE rate between those implanted in CAA or in CAP. However, CAA group showed a higher ST rate.
•Follow-up after implantation of covered stents (CS) is limited•This is the first study that specifically analyzes outcomes of new-generation CS.•After 22 ± 16 months, the rate of major cardiac adverse events is 7.1%.•MACE rate was similar between those implanted in aneurysms or perforations.•Higher stent thrombosis rate was observed in those implanted in coronary aneurysms.</description><subject>Coronary artery aneurysms</subject><subject>Coronary artery perforations</subject><subject>Covered stents</subject><issn>1553-8389</issn><issn>1878-0938</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1r3DAQhkVpINtt_0EOOvZiRx9rWe6hsJi2WVhIaJKzkKVxVottuZK8sIf892rZngsDM8PMvMz7IHRHSUkJFffH0ugQ4FQywkhJZElo_QGtqKxlQRouP-a6qnghuWxu0acYj4Twmol6hd7bwU3O6AE_Lsn4ESLe9gkC3o3zoKekk_MT9j1-8sN5CZAOeoKi9ScIYHHrOz2koj0EP7plxM8JphS_4d0U3dshRdznAU4HwE96PoclFs-zdhP-DW8upnD-jG56PUT48i-v0evPHy_tQ7F__LVrt_vCcN6korO95KymjWl0IztOBM0NF7ZnzDYNqUgtpDXMVIIJqQ3dGLDGdr3uRGWJ4Gv09ao7B_9ngZjU6KKBITsEv0TFNlyKuuI51mhzXTXBxxigV3Nwow5nRYm60FZHdaWtLrQVkSrTzmffr2eQbZwcBBWNgyn_4QKYpKx3_xf4C_APjO4</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Jurado-Román, Alfonso</creator><creator>Rodríguez, Oriol</creator><creator>Amat, Ignacio</creator><creator>Romani, Sebastián A.</creator><creator>García-Touchard, Arturo</creator><creator>Cruz-González, Ignacio</creator><creator>Benito-González, Tomás</creator><creator>Fernández-Cisnal, Agustín</creator><creator>Córdoba-Soriano, Juan G.</creator><creator>Subinas, Asier</creator><creator>Hernández-Antolín, Rosana</creator><creator>Bayón, Jeremías</creator><creator>García-Tejada, Julio</creator><creator>Salinas, Pablo</creator><creator>Cortés, Carlos</creator><creator>Lozano, Fernando</creator><creator>Bastante, Teresa</creator><creator>Núñez-Gil, Iván J.</creator><creator>Moreno, Raúl</creator><creator>López-Sendón, José Luis</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202108</creationdate><title>Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry</title><author>Jurado-Román, Alfonso ; Rodríguez, Oriol ; Amat, Ignacio ; Romani, Sebastián A. ; García-Touchard, Arturo ; Cruz-González, Ignacio ; Benito-González, Tomás ; Fernández-Cisnal, Agustín ; Córdoba-Soriano, Juan G. ; Subinas, Asier ; Hernández-Antolín, Rosana ; Bayón, Jeremías ; García-Tejada, Julio ; Salinas, Pablo ; Cortés, Carlos ; Lozano, Fernando ; Bastante, Teresa ; Núñez-Gil, Iván J. ; Moreno, Raúl ; López-Sendón, José Luis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-bdf832719c9a98b306171936df22d99050768dc2c56268ac14cedcdbfab65d063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Coronary artery aneurysms</topic><topic>Coronary artery perforations</topic><topic>Covered stents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jurado-Román, Alfonso</creatorcontrib><creatorcontrib>Rodríguez, Oriol</creatorcontrib><creatorcontrib>Amat, Ignacio</creatorcontrib><creatorcontrib>Romani, Sebastián A.</creatorcontrib><creatorcontrib>García-Touchard, Arturo</creatorcontrib><creatorcontrib>Cruz-González, Ignacio</creatorcontrib><creatorcontrib>Benito-González, Tomás</creatorcontrib><creatorcontrib>Fernández-Cisnal, Agustín</creatorcontrib><creatorcontrib>Córdoba-Soriano, Juan G.</creatorcontrib><creatorcontrib>Subinas, Asier</creatorcontrib><creatorcontrib>Hernández-Antolín, Rosana</creatorcontrib><creatorcontrib>Bayón, Jeremías</creatorcontrib><creatorcontrib>García-Tejada, Julio</creatorcontrib><creatorcontrib>Salinas, Pablo</creatorcontrib><creatorcontrib>Cortés, Carlos</creatorcontrib><creatorcontrib>Lozano, Fernando</creatorcontrib><creatorcontrib>Bastante, Teresa</creatorcontrib><creatorcontrib>Núñez-Gil, Iván J.</creatorcontrib><creatorcontrib>Moreno, Raúl</creatorcontrib><creatorcontrib>López-Sendón, José Luis</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular revascularization medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jurado-Román, Alfonso</au><au>Rodríguez, Oriol</au><au>Amat, Ignacio</au><au>Romani, Sebastián A.</au><au>García-Touchard, Arturo</au><au>Cruz-González, Ignacio</au><au>Benito-González, Tomás</au><au>Fernández-Cisnal, Agustín</au><au>Córdoba-Soriano, Juan G.</au><au>Subinas, Asier</au><au>Hernández-Antolín, Rosana</au><au>Bayón, Jeremías</au><au>García-Tejada, Julio</au><au>Salinas, Pablo</au><au>Cortés, Carlos</au><au>Lozano, Fernando</au><au>Bastante, Teresa</au><au>Núñez-Gil, Iván J.</au><au>Moreno, Raúl</au><au>López-Sendón, José Luis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry</atitle><jtitle>Cardiovascular revascularization medicine</jtitle><date>2021-08</date><risdate>2021</risdate><volume>29</volume><spage>22</spage><epage>28</epage><pages>22-28</pages><issn>1553-8389</issn><eissn>1878-0938</eissn><abstract>The main indication of covered stents (CS) is coronary artery perforation (CAP), but, they have been increasingly used in other scenarios. Data on the long-term follow-up of CS is limited, and no studies have been conducted specifically using new-generation polyurethane-covered cobalt-chromium Papyrus CS. Purpose: to evaluate the clinical outcomes after hospital discharge of Papyrus CS and to compare their outcome after implantation in CAP or coronary artery aneurysms (CAA).
We evaluated the baseline clinical characteristics, lesion subsets, procedural features and the outcomes after initial discharge of Papyrus CS implanted in 17 high-PCI-volume centers.
127 Papyrus CS were implanted in 108 patients (68 ± 1 years; 82.8% male) admitted for stable coronary disease (32.3%), NSTEMI (42.4%) or STEMI (25.3%). The number of CS per patient was 1.2 ± 0.6 (diameter: 3.5 ± 1.7 mm; length: 18.5 ± 3.7 mm). Angiographic success rate was 96%. CS diameter was larger in CAA (CAP:3.04 ± 0.5 mm vs CAA:4.1 ± 2.7 mm; p = .022). Intracoronary imaging techniques were used more frequently in CAA (p < .0001). After a mean follow-up of 22 ± 16 months, the major cardiovascular adverse events (MACE) rate was 7.1% [cardiac death: 2%, Myocardial infarction: 5%, Target Lesion Revascularization: 5% and Stent Thrombosis (ST): 3%]. MACE rate was similar in CAP (7.7%) and CAA (7.1%) (p = .9). However, CAA showed a higher ST rate (CAP: 0% vs CA: 7.1%; p = .04).
After hospital discharge, clinical outcomes after Papyrus CS implantation are acceptable (considering the clinical scenario and compared with other treatment alternatives) with no significant differences in the MACE rate between those implanted in CAA or in CAP. However, CAA group showed a higher ST rate.
•Follow-up after implantation of covered stents (CS) is limited•This is the first study that specifically analyzes outcomes of new-generation CS.•After 22 ± 16 months, the rate of major cardiac adverse events is 7.1%.•MACE rate was similar between those implanted in aneurysms or perforations.•Higher stent thrombosis rate was observed in those implanted in coronary aneurysms.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.carrev.2020.08.017</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1553-8389 |
| ispartof | Cardiovascular revascularization medicine, 2021-08, Vol.29, p.22-28 |
| issn | 1553-8389 1878-0938 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2438675375 |
| source | Elsevier ScienceDirect Journals |
| subjects | Coronary artery aneurysms Coronary artery perforations Covered stents |
| title | Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T12%3A10%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Outcomes%20After%20Implantation%20of%20Polyurethane-Covered%20Cobalt-Chromium%20Stents:%20Insights%20from%20the%20Papyrus-Spain%20Registry&rft.jtitle=Cardiovascular%20revascularization%20medicine&rft.au=Jurado-Rom%C3%A1n,%20Alfonso&rft.date=2021-08&rft.volume=29&rft.spage=22&rft.epage=28&rft.pages=22-28&rft.issn=1553-8389&rft.eissn=1878-0938&rft_id=info:doi/10.1016/j.carrev.2020.08.017&rft_dat=%3Cproquest_cross%3E2438675375%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2438675375&rft_id=info:pmid/&rft_els_id=S1553838920304863&rfr_iscdi=true |